Better Therapeutics has tapped Frank Karbe as president and CEO. He succeeds the company’s current CEO and co-founder, Kevin Appelbaum, in the role.
Prior to arriving at Better Therapeutics, Karbe worked as president and CFO at Myovant Sciences and, before that, as EVP and chief financial officer at Exelixis.
“On behalf of the board of directors, we are grateful to Kevin for taking Better Therapeutics from a mere idea to a company on the cusp of potentially commercializing our first product and creating a better way to treat metabolic diseases,” co-founder and executive chairman David Perry said in a statement. “And we are proud to welcome Frank, whose involvement in the launch of three commercial products, success in raising over $4 billion for two public biotech companies and integral role in leading business development activities speak to a track record of tangible successes in the life sciences industry.”